• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Uncharacterized protein C18orf8 (C18orf8)

ACP13224

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP13224 Target NameRMC1
Target SynonymsC18orf8; Chromosome 18 open reading frame 8 ; Colon cancer associated protein Mic1 ; Colon cancer-associated protein Mic1; HsT2591 ; Mic-1; MIC1; MIC1_HUMAN; Uncharacterized protein C18orf8FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-657
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ96DM3
Background Information
  • Uniprot Id

    Q96DM3

  • Target Species

    Human

  • Target Name

    RMC1

  • Target Full Name

    Regulator of MON1-CCZ1 complex

  • Target Function

    Componement of the CCZ1-MON1 RAB7A guanine exchange factor (GEF). Acts as a positive regulator of CCZ1-MON1A/B function necessary for endosomal/autophagic flux and efficient RAB7A localization.

  • Target Subcellular Location

    Lysosome membrane. Late endosome membrane.

  • Target Protein Families

    RMC1 family

  • Target Synonyms

    C18orf8; Chromosome 18 open reading frame 8 ; Colon cancer associated protein Mic1 ; Colon cancer-associated protein Mic1; HsT2591 ; Mic-1; MIC1; MIC1_HUMAN; Uncharacterized protein C18orf8

  • Target Background

    This gene encodes a colon cancer associated protein.

Inquire Recombinant Human Uncharacterized protein C18orf8 (C18orf8) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification